Flush with cash, com­pu­ta­tion­al chem­istry pi­o­neer Nim­bus con­sid­ers next steps. Is an IPO in the fu­ture?

When Bruce Booth helped launch Nim­bus Ther­a­peu­tics back in 2009, it was dif­fi­cult to find co-in­vestors will­ing to back the com­pa­ny’s pi­o­neer­ing com­pu­ta­tion­al chem­istry plat­form …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER